title: Second European multi-disciplinary conference of national strategies for Chlamydia trach. and human papillomavirus NSCP conf. in Berlin, 2013 enhanced detection, management and surveillance of sexually transmitted infections in Europe are essential!
abstract: There is a need for updated guidance on detection, management and surveillance of sexually transmitted infections (STIs). Chlamydia, gonorrhoea and syphilisreporting needs to be mandatory in more European countries to aid collection of data. More widespread Chlamydia screening is needed in many countries as this is the only way to reduce complications. The role of Human Papillomavirus (HPV) screening in a situation where the prevalence of HPV infection has dropped significantly was also discussed in the context of the high cost of screening, the need for a relatively complex infrastructure, particularly in developing countries, and falling vaccination costs. An integrated HPV vaccination and screening policy could be the most appropriate with vaccination at 9-13 years as recommended by WHO and a single HPV screen at 35-39 years, possibly repeated thereafter every 10 years. Female and male HPV vaccination programmes could lead to near elimination of genital warts in both females and males. Surveillance of STIsshould be intensified where needed; additional or better quality data should be collected including reasons for testing, denominator data to estimate positivity rates, diagnostic methods, concurrent STIs, sexual orientation and country of acquisition; more analytical rather than descriptive epidemiology is needed.
authors.affiliation: University of Latvia, Riga, Latvia.
authors.forename: D
authors.initials: D
authors.lastname: Ozolins
authors.affiliation: University of Florence, Florence, Italy.
authors.forename: M M
authors.initials: MM
authors.lastname: D' Elios
authors.affiliation: County Hospital of Halland, Halmstad, Sweden.
authors.forename: T
authors.initials: T
authors.lastname: Ripa
authors.affiliation: London School of Hygiene and Tropical Medicine, London, United Kingdom.
authors.forename: R
authors.initials: R
authors.lastname: Bailey
authors.affiliation: Queensland University of Technology, Brisbane, Australia.
authors.forename: P
authors.initials: P
authors.lastname: Timms
authors.affiliation: European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
authors.forename: G
authors.initials: G
authors.lastname: Spiteri
authors.affiliation: European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
authors.forename: K
authors.initials: K
authors.lastname: Haar
authors.affiliation: Orebro University Hospital, Orebro, Sweden.
authors.forename: M
authors.initials: M
authors.lastname: Unemo
mesh_terms: D002690:Chlamydia Infections / Q000175:diagnosis / Q000517:prevention & control*; D002692:Chlamydia trachomatis; D003226:Congresses as Topic; D005060:Europe; D005260:Female; D006801:Humans; D008297:Male; D008403:Mass Screening; D030361:Papillomavirus Infections / Q000175:diagnosis / Q000517:prevention & control*; D012749:Sexually Transmitted Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control*; D014611:Vaccination